Cell & Gene Therapy World Asia 2025
As the region emerges as a global leader in regenerative medicine, Cell & Gene Therapy World Asia 2025 (#CGTAsia2025) returns as Asia’s most anticipated CGT knowledge-sharing conference for the 9th year! Designed to connect and empower stakeholders from the cell and gene therapy ecosystem, the event provides an unparalleled platform to explore the latest advancements in cell therapies, gene therapies, and CAR-T technologies.

Event Highlights
- Cutting-Edge Agenda: Focus on next-generation gene editing, vector manufacturing strategies, CAR-T advancements, commercialisation strategies, and clinical breakthroughs.
- Regional Success Stories: Insights from leading biopharma companies in China, Japan, South Korea, and Taiwan, as well as key innovators from Southeast Asia and Australia.
- Technical Expertise: Presentations by international CGT companies and Big Pharma on manufacturing technologies, analytical characterisation, and supply chain innovations.
- Regulatory Outlook: Updates on East Asia’s evolving regulatory landscape, including recent advancements in government and regulatory support for regenerative medicine development.
- Networking Opportunities: A dynamic platform for fostering strategic partnerships and knowledge-sharing through panel discussions, exhibitions, poster sessions, and 1-1 networking meetings.
Get all the latest updates
No spam. Just interesting articles, and exclusive updates in your inbox every week.